Piper Sandler Sticks to Its Buy Rating for Inovio Pharmaceuticals (INO)
at www.tipranks.com (Fri, 13-Mar 7:56 AM)
Inovio targets October 30 PDUFA date for INO-3107 approval while extending cash runway into Q4 2026
at seekingalpha.com (Thu, 12-Mar 9:52 PM)
Inovio Pharmaceuticals GAAP EPS of -$1.81 beats by $0.42
at seekingalpha.com (Thu, 12-Mar 4:10 PM)
Major earnings expected after the bell on Thursday include:
at seekingalpha.com (Thu, 12-Mar 10:00 AM)
Options Volatility and Implied Earnings Moves Today, March 12, 2026
at www.tipranks.com (Thu, 12-Mar 8:05 AM)
Inovio Pharmaceuticals Q4 2025 Earnings Preview
at seekingalpha.com (Wed, 11-Mar 5:35 PM)
